Association of dyslipidemia with diabetic retinopathy in type 2 diabetes mellitus patients: A hospital-based study

Background: Dyslipidemia is an important risk factor that can lead to the progression of retinopathy (DR). Diabetic dyslipidemia with low high-density lipoprotein (HDL) and increased triglycerides (TGs) are seen frequently among Type 2 diabetic mellitus. Aims and Objectives: (1) To assess the level...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Kalaimamani Ezhilvendhan, Anitha Sathiyamoorthy, B Jey Prakash, B Saravana Bhava, Arjun Shenoy
Formato: article
Lenguaje:EN
Publicado: Wolters Kluwer Medknow Publications 2021
Materias:
Acceso en línea:https://doaj.org/article/c75dade77d1c471286dff423826b2513
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:c75dade77d1c471286dff423826b2513
record_format dspace
spelling oai:doaj.org-article:c75dade77d1c471286dff423826b25132021-11-19T12:15:52ZAssociation of dyslipidemia with diabetic retinopathy in type 2 diabetes mellitus patients: A hospital-based study0975-740610.4103/jpbs.jpbs_164_21https://doaj.org/article/c75dade77d1c471286dff423826b25132021-01-01T00:00:00Zhttp://www.jpbsonline.org/article.asp?issn=0975-7406;year=2021;volume=13;issue=6;spage=1062;epage=1067;aulast=Ezhilvendhanhttps://doaj.org/toc/0975-7406Background: Dyslipidemia is an important risk factor that can lead to the progression of retinopathy (DR). Diabetic dyslipidemia with low high-density lipoprotein (HDL) and increased triglycerides (TGs) are seen frequently among Type 2 diabetic mellitus. Aims and Objectives: (1) To assess the level of serum lipids (total cholesterol, TGs, HDL, and low-density lipoprotein [LDL]) among type 2 diabetes patients. (2) To determine the association between serum lipid levels and DR. Materials and Methods: This was a hospital-based cross-sectional study conducted in a tertiary care hospital in Salem from September 2018 to March 2020 with a sample size of 200. Details of their diabetic history were obtained. Patients were evaluated for their HbA1C levels, hypertension, and lipid profile status. Early treatment DR Study system was used to classify DR. Low density lipoprotein cholesterol was calculated by Freidewald's equation. Results: This study showed a significant association among DR and LDL cholesterol. DR with raised LDL, TGs levels, and lowered HDL on adjusted analysis. There was strong association between DR and serum cholesterol in unadjusted analysis; however, there was no association when adjusted for factors such as age, gender, duration of diabetes, and glycemic control. Majority of participants were males (57.5%) with a male: female = 1.35:1. The mean age of the patients in our study was 57.8 (5.8) years and 54.4 (6.6) years in patients with DR and patients without retinopathy, and it was found to be statistically significant. There was a significant difference in the duration of diabetes with the presence of DR and the patients with DR were having longer duration of diabetes (7.9 vs. 6.2 years; P < 0.001). Moderate nonproliferative diabetic retinopathy (NPDR) was found to be present in 41.0% of eyes followed by mild NPDR (20.5% eyes). Proliferative diabetic retinopathy was present only in 9.5%, and the severity of retinopathy was associated only with the HDL level, and there was no association found with total cholesterol, TG, and LDL cholesterol. Conclusion: A statistically significant correlation was found between dyslipidemia and the severity of DR among Type 2 diabetic patients.Kalaimamani EzhilvendhanAnitha SathiyamoorthyB Jey PrakashB Saravana BhavaArjun ShenoyWolters Kluwer Medknow Publicationsarticlediabetic mellitusdyslipidemiaearly treatment diabetic retinopathy studyPharmacy and materia medicaRS1-441Analytical chemistryQD71-142ENJournal of Pharmacy and Bioallied Sciences, Vol 13, Iss 6, Pp 1062-1067 (2021)
institution DOAJ
collection DOAJ
language EN
topic diabetic mellitus
dyslipidemia
early treatment diabetic retinopathy study
Pharmacy and materia medica
RS1-441
Analytical chemistry
QD71-142
spellingShingle diabetic mellitus
dyslipidemia
early treatment diabetic retinopathy study
Pharmacy and materia medica
RS1-441
Analytical chemistry
QD71-142
Kalaimamani Ezhilvendhan
Anitha Sathiyamoorthy
B Jey Prakash
B Saravana Bhava
Arjun Shenoy
Association of dyslipidemia with diabetic retinopathy in type 2 diabetes mellitus patients: A hospital-based study
description Background: Dyslipidemia is an important risk factor that can lead to the progression of retinopathy (DR). Diabetic dyslipidemia with low high-density lipoprotein (HDL) and increased triglycerides (TGs) are seen frequently among Type 2 diabetic mellitus. Aims and Objectives: (1) To assess the level of serum lipids (total cholesterol, TGs, HDL, and low-density lipoprotein [LDL]) among type 2 diabetes patients. (2) To determine the association between serum lipid levels and DR. Materials and Methods: This was a hospital-based cross-sectional study conducted in a tertiary care hospital in Salem from September 2018 to March 2020 with a sample size of 200. Details of their diabetic history were obtained. Patients were evaluated for their HbA1C levels, hypertension, and lipid profile status. Early treatment DR Study system was used to classify DR. Low density lipoprotein cholesterol was calculated by Freidewald's equation. Results: This study showed a significant association among DR and LDL cholesterol. DR with raised LDL, TGs levels, and lowered HDL on adjusted analysis. There was strong association between DR and serum cholesterol in unadjusted analysis; however, there was no association when adjusted for factors such as age, gender, duration of diabetes, and glycemic control. Majority of participants were males (57.5%) with a male: female = 1.35:1. The mean age of the patients in our study was 57.8 (5.8) years and 54.4 (6.6) years in patients with DR and patients without retinopathy, and it was found to be statistically significant. There was a significant difference in the duration of diabetes with the presence of DR and the patients with DR were having longer duration of diabetes (7.9 vs. 6.2 years; P < 0.001). Moderate nonproliferative diabetic retinopathy (NPDR) was found to be present in 41.0% of eyes followed by mild NPDR (20.5% eyes). Proliferative diabetic retinopathy was present only in 9.5%, and the severity of retinopathy was associated only with the HDL level, and there was no association found with total cholesterol, TG, and LDL cholesterol. Conclusion: A statistically significant correlation was found between dyslipidemia and the severity of DR among Type 2 diabetic patients.
format article
author Kalaimamani Ezhilvendhan
Anitha Sathiyamoorthy
B Jey Prakash
B Saravana Bhava
Arjun Shenoy
author_facet Kalaimamani Ezhilvendhan
Anitha Sathiyamoorthy
B Jey Prakash
B Saravana Bhava
Arjun Shenoy
author_sort Kalaimamani Ezhilvendhan
title Association of dyslipidemia with diabetic retinopathy in type 2 diabetes mellitus patients: A hospital-based study
title_short Association of dyslipidemia with diabetic retinopathy in type 2 diabetes mellitus patients: A hospital-based study
title_full Association of dyslipidemia with diabetic retinopathy in type 2 diabetes mellitus patients: A hospital-based study
title_fullStr Association of dyslipidemia with diabetic retinopathy in type 2 diabetes mellitus patients: A hospital-based study
title_full_unstemmed Association of dyslipidemia with diabetic retinopathy in type 2 diabetes mellitus patients: A hospital-based study
title_sort association of dyslipidemia with diabetic retinopathy in type 2 diabetes mellitus patients: a hospital-based study
publisher Wolters Kluwer Medknow Publications
publishDate 2021
url https://doaj.org/article/c75dade77d1c471286dff423826b2513
work_keys_str_mv AT kalaimamaniezhilvendhan associationofdyslipidemiawithdiabeticretinopathyintype2diabetesmellituspatientsahospitalbasedstudy
AT anithasathiyamoorthy associationofdyslipidemiawithdiabeticretinopathyintype2diabetesmellituspatientsahospitalbasedstudy
AT bjeyprakash associationofdyslipidemiawithdiabeticretinopathyintype2diabetesmellituspatientsahospitalbasedstudy
AT bsaravanabhava associationofdyslipidemiawithdiabeticretinopathyintype2diabetesmellituspatientsahospitalbasedstudy
AT arjunshenoy associationofdyslipidemiawithdiabeticretinopathyintype2diabetesmellituspatientsahospitalbasedstudy
_version_ 1718420157478469632